TickerFactsScreenerDevelopers

LIGAND PHARMACEUTICALS INC (LGND) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $28.75M2009: $16.03M2010: $3.35M2011: $7.04M2012: $12.38M2013: $11.64M2014: $160.20M2015: $97.43M2016: $18.75M2017: $20.62M2018: $117.16M2019: $71.54M2020: $47.62M2021: $19.52M2022: $45.01M2023: $22.95M2024: $72.31M2025: $174.93M$174.93M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$174.93M+141.9%
2024$72.31M+215.0%
2023$22.95M-49.0%
2022$45.01M+130.5%
2021$19.52M-59.0%
2020$47.62M-33.4%
2019$71.54M-38.9%
2018$117.16M+468.2%
2017$20.62M+10.0%
2016$18.75M-80.8%
2015$97.43M-39.2%
2014$160.20M+1276.4%
2013$11.64M-6.0%
2012$12.38M+75.8%
2011$7.04M+110.4%
2010$3.35M-79.1%
2009$16.03M-44.2%
2008$28.75M—